- The FDA has approved Globus Medical Inc's GMED Excelsius3D, an intelligent intraoperative 3-in-1 imaging system.
- The imaging platform consolidates 360o cone-beam CT, fluoroscopy, and high-resolution digital radiography into one unified solution, eliminating the need for multiple imaging systems during one procedure.
- The system offers omnidirectional wheels and the elimination of a separate viewing station.
- Globus Medical is ramping up production and preparing for commercial release in Q4 of 2021.
- Excelsius3D is a mobile X-ray system designed for 2D fluoroscopy, 2D digital radiography, and 3D imaging of adult and pediatric patients.
- Price Action: GMED shares closed 2.04% higher at $77.96 on Monday.
- Related content: Benzinga's Full FDA Calendar.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
